Drug Trial Radar · NCT07051993
A Study to Evaluate the Relative Bioavailability of Two Tablet Formulations Compared to Capsule Formulation and the Effect of Food and Proton Pump Inhibitor on ZN-A-1041 Tablet(s) in Healthy Participants
Last checked: Nov 20, 2026Latest source record: Oct 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Jun 27, 2025
Primary completion
Jul 12, 2025
Study completion Jul 12, 2025
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jul 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, open-label, randomized, two-part study to evaluate the relative bioavailability (rBA) of two tablet formulations compared to the capsule formulation of ZN-A-1041 (Part 1). Part 2 of the study will evaluate the effect of food and rabeprazole on the ZN-A-1041 tablet formulation. No participants were enrolled in Part 2 of the study as it has been cancelled.
Conditions
- Healthy Participants
Interventions
ZN-A-1041Drug
Participants will be administered either a ZN-A-1041 capsule or a tablet orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Observed Concentration (Cmax)Time frame: Days 1-12 (Part 1)
- Area Under the Concentration-Time curve from Hour 0 to the Last Measurable Concentration (AUC0-t)Time frame: Days 1-12 (Part 1)
- AUC Extrapolated to Infinity (AUC0-inf)Time frame: Days 1-12 (Part 1)
- Geometric Mean Ratio and Associated 90% Confidence Interval (CI) of CmaxTime frame: Days 1-12 (Part 1)
- Geometric Mean Ratio and Associated 90% CI of AUC0-tTime frame: Days 1-12 (Part 1)
- Geometric Mean Ratio and Associated 90% CI of AUC0-infTime frame: Days 1-12 (Part 1)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fortrea Leeds CRU
Leeds, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.